Stay updated on PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.

Latest updates to the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page
- CheckyesterdayChange DetectedA site-wide notice announces updates about NIH websites and says some content may use “Super Intelligence” (SI) instead of “Artificial Intelligence” (AI) during the transition.SummaryDifference1%

- Check7 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site footer’s revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content. This indicates access to the study record is blocked.SummaryDifference17%

- Check56 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a minor site release. The change represents a routine maintenance update to the page template and underlying platform without altering study information.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page shows Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor system or template update without changes to study data.SummaryDifference0.1%

Stay in the know with updates to PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.